Welcome from the President
The role of pre-operative histology in nephroureterectomy: The UK experience : 1
24-Month functional results of a prospective randomized controlled study comparing greenLight XPS to TURP for durability, efficacy and safety (GOLIATH) : 2
Altered expression of markers of epithelial-to-mesenchymal transition at the extraprostatic extension component of locally invasive prostate cancers : 3
Workplace patterns and urothelial bladder cancer phenotype – can occupation increase the risk of developing advanced disease? : 4
Multilocular cystic renal cell carcinoma has an excellent prognosis regardless of size or pathologic T-stage: Results of a large population-level study : 5
Exploring the potential of Fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG PET) to improve clinical decision making in patients with Retroperitoneal fibrosis (RPF) : 6
Workplace patterns and urothelial bladder cancer phenotype – can occupation increase the risk of developing advanced disease? : 7
Celecoxib for the treatment of non-muscle invasive bladder cancer (NMIBC): Results of the randomised BOXIT trial (CRUK/07/004) : 8
Real life experience: Recurrence free survival at 3 years is significantly better with Hexvix® PDD-TURBT when compared with Good Quality White Light TURBT (GQ-WLTURBT) in new non muscle invasive bladder cancer (NMIBC) – a prospective controlled study : 9
HYMN: a randomised controlled phase III trial comparing hyperthermia plus mitomycin to a second course of BCG or institutional standard in patients with recurrence of non-muscle invasive bladder cancer (NMIBC) following induction or maintenance BCG therapy : 10
Oncological outcomes following intracorporeal robotic cystectomy versus open radical cystectomy: an analysis of 184 patients : 11
Robotic radical cystectomy with intracorporeal urinary diversion: Impact on an established enhanced recovery protocol : 12
Trends in upper tract stone disease in England: Evidence from the Hospital Episodes Statistics (HES) database : P1
Multicentre validation of the guy's stone score – Inter-observer reliability and correlation with stone clearance : P2
Primary care surveillance of asymptomatic small renal calculi : P3
The management of urinary stones in the octogenarians : P4
Extracorporeal shockwave lithotripsy – A multicentre UK snapshot study : P5
Do solitary renal stones that fail ESWL require treatment? : P6
Prospective outcomes of ultra-mini percutaneous nephrolithotomy (UMP): A consecutive single centre cohort study of 98 patients : P7
Successful treatment of lower pole renal calculi (10–20 mm) using a trimodal approach based on primary lithotripsy: Large single institution study : P8
The prevalence of altered calcium metabolism amongst stone formers : P9
Prevalence and treatment response of recurrent renal stone formers with hypercalciuria and distal renal tubular acidosis : P10
Renal angiomyolipomas >4 cm do not always need treatment: A study of their natural history : P11
Exploring the potential of Fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG PET) to improve clinical decision making in patients with Retroperitoneal fibrosis (RPF) : P12
10 year experience of robot assisted laparoscopic pyeloplasty : P14
10 year experience of total laparoscopic donor nephrectomy in a tertiary UK urology and transplant centre : P15
Achieving quality assurance of prostate cancer surgery during reorganisation of cancer services in London : P16
Radical prostatectomy outcome data: Which parameters are representative and reliable to publish? : P17
Robotic-assisted laparoscopic radical prostatectomy (RALP) in the north of England: A multicentre study focussing on perioperative and early oncological results : P18
Open versus robotic surgery – A single centre comparison of 1000 consective radical prostatectomies : P19
Robot assisted laparoscopic prostatectomy is associated with superior oncological outcome in larger prostates : P20
Pentafecta outcomes following robot assisted radical prostatectomy : P21
Evolution of a contemporary robotic prostatectomy service in the UK : P22
Meeting the challenge of higher risk prostate cancer: a single surgeon's experience of the benefit of robotic over laparoscopic surgery : P23
Early continence rates vary by surgical technique for urethrovesical anastomosis during robotic assisted radical prostatectomy : P24
Dehydrated human amniotic membrane allograft nerve wrap around the prostatic neurovascular bundle accelerates early return to continence and potency following radical robot assisted radical prostatectomy (RARP): A propensity score matched analysis : P25
Robot-assisted radical prostatectomy for radiorecurrent prostate cancer : P26
Robotic versus open salvage radical prostatectomies: A two centre study : P27
Is long-term urinary morbidity after prostate brachytherapy under-reported? : P28
Educational seminars increase confidence and decreases dropout from active surveillance : P29
Can PSA density identify prostate cancer progression in men on imaging guided active surveillance? : P30
The evolution of urinary diversion and the orthotopic neobladder : P31
Adam's lost rib : P32
The history of vasectomy : P33
Stones of great Britons : P34
Willard E Goodwin a urologist who one day made a mistake but it was a good one! : P35
The lost urologist: Edward Canny Ryall : P36
History of cryotherapy for prostate cancer : P37
The history of pelvic organ prolapse from antiquity to present day : P38
Post-transurethral prostatectomy suprapubic pressure test: A tribute to the life and accomplishments of William Wardill (1894–1960) : P39
Mitomycin-C: Historical aspects of the discovery of most commonly used chemotherapy agent in urology : P40
The evolution of testicular prostheses: greater patient satisfaction or are we still dropping the ball? : P41
The history of penile enhancement – to cut a short story long : P42
An observational study of erectile dysfunction, infertility, and prostate cancer in regular cyclists: Cycling for health UK study : P43
Vasectomy, pain, sexual dysfunction & relationship breakdown – Large cohort study : P44
Optimal timing of semen analysis following vasectomy : P45
Islam and the urinary tract – A contemporary theological and surgical dilemma : P46
The role of anticoagulation in emergency haematuria admissions : P47
Is scrotal ultrasound scan necessary in patients with clinically suspected benign testis pathology? : P48
CT urography as the first line investigation for haematuria: Is it truly indicated? A single centre analysis of the use of CT urography in the haematuria clinic : P49
Use of percutaneous nephrostomies in the management of obstructive uropathy due to malignancy : P50
Long-term nephrostomy kidney drainage – A hidden challenge for urology services : P51
Targeted antimicrobial prophylaxis for trans-rectal prostate biopsy: Does it reduce septic complications? : P52
Gentamicin significantly reduces infection related hospital admissions post transrectal ultrasound guided biopsy of the prostate : P53
Variation in gentamicin prophylaxis for urological procedures: evidence based or traditional practice? : P54
Antibiotic prophylaxis for urological procedures across the UK: Why such variations in practice? : P55
A multi-centre analysis of antibiotic susceptability of urinary tract isolates in patients with ureteric stents and associated UTI : P56
Is Fournier's gangrene still a death sentence? : P57
The association between the ICIQ-LUTS& the ICIQ-bladder diary in assessing LUTS : P58
Female bladder outflow obstruction: An increasing but under diagnosed phenomena : P59
Persistence with mirabegron therapy for overactive bladder: A real-life experience : P60
OnabotulinumtoxinA reduces urinary incontinence and urgency and improves quality of life in patients with overactive bladder regardless of incontinence severity at baseline : P61
The success of sacral neuromodulation in treating patients with acontractile voiding dysfunction : P62
Does bilateral sacral nerve stimulation confer significant improvement in urological symptoms compared with unilateral stimulation? : P63
Single centre randomised pilot study of two regimens (30 mins daily or 30 mins weekly for 12 weeks) of transcutaneous tibial nerve stimulation for the treatment of patients with overactive bladder (OAB) syndrome : P64
Withstanding the test of time; Urethral bulking injections (Deflux) for urinary stress incontinence : P65
The role of bladder stretching in maintaining bladder health: Plasma cytokine levels in catheterised patients using valves or on free drainage : P66
Intractable long-term catheter problems managed by intradetrusor botulinum toxin-A (BTxA) : P67
Management and outcomes of urinary tract fistula repair at a single institution : P68
Renal tumor biopsy for small renal masses: A large single-centre 13-year experience : P69
Surveillance of Bosniak (2F) renal cysts: Rationalising follow up : P70
Multilocular cystic renal cell carcinoma has an excellent prognosis regardless of size or pathologic T-stage: Results of a large population-level study : P71
The role of pre-operative histology in nephroureterectomy: The UK experience : P72
Achievement of trifecta with early unclamping technique during robotic partial nephrectomy : P73
A cut above? Retrospective review of a dual-centre experience – Inferior vena cava resection in renal and adrenal cancer surgery with curative intention : P74
Surgeon volume and outcome for nephrectomy surgery using the British Association of Urological Surgeons (BAUS) nephrectomy database : P75
Consultant outcome publication for partial nephrectomy: Is the ‘Trifecta’ being achieved? : P76
Oncological outcomes following radical nephrectomy with deep hypothermic circulatory arrest (DHCA) in patients with supra-diaphragmatic thrombus extension : P77
Cardiovascular outcomes in kidney cancer patients : P78
Establishing a benchmark for long term functional and oncological outcomes following nephron-sparing surgery in single kidneys : P79
Outcomes of radical nephrectomy for renal masses in patients with end stage renal disease : P80
Pushing the boundaries of robotic partial nephrectomy: A multi-centre comparison of the peri-operative, functional and oncological outcomes for T1a and T1b tumours : P81
Catheter and drain free (Tubeless) radical & partial nephrectomy – The future : P82
A culture of open reporting and assessment of harms results in improved quality of bladder tumour resections and biopsies: A closed loop audit of a district general hospital : P83
Chaperone use in urology – A study examining the current opinions and practices of UK urological surgeons : P84
Can an operative coding sticker improve remuneration for upper tract stone-related procedures? : P85
‘WhatsApp Doc?’ Evaluating a novel modality of communication amongst urology team members to promote patient safety : P86
Validation of the BAUS human cadaver training programme : P87
The use of fresh frozen cadavers for the teaching of Holmium laser enucleation of prostate, Thulium prostate resection and high power KTP laser vapourisation : P88
Development of training pathway for robot assisted prostatectomy and evaluation of learning curve using observational methodology : P89
‘Registrar of the week’ and a bespoke ward round checklist optimise the quality of urology in-patient care : P90
‘The hidden workload’ – What is the true extent and clinical outcomes of the inpatient urology consultation? : P91
The one-stop clinic: A snap-shot of current practice : P92
Micro-dissection TeSE vs conventional TeSE for non-obstructive azoospermia : P93
Cytogenetic abnormalities in men with subfertility. Analysis of the frequency of abnormalities and determination of a threshold sperm concentration for genetic testing : P94
The clinical value of assessing sperm chromosomal aneuploidy in couples undergoing failed intracytoplasmic sperm injection (ICSI) and its correlation with semen parameters : P95
Management and outcomes of patients with peno-scrotal extramammary pagets disease : P96
Does the preoperative neutrophil to lymphocyte ratio have any prognostic value in advanced penile cancer? : P97
The management of sentinel node non-visualisation in penile squamous cell carcinoma – Is it worth repeating the procedure? : P98
Patient reported outcomes of glans resurfacing for penile lichen sclerosis and malignancy : P99
Is wide local excision feasible for the management of small volume tumours of the glans penis? : P100
Safety and effectiveness of collagenase clostridium histolyticum (CCH) treatment in EU Patients with Peyronie's disease: A comparison of EU enrolled subjects versus all subjects enrolled in a phase 3 open-label study : P101
Penile implants act as a tissue expander and may lead to an increase in penile length and girth : P102
Tunical plication for the treatment of penile curvature – Factors predicting residual and recurrent curvature : P103
The effect of varicocele embolisation in the treatment of orchalgia : P104
Management of urethral stricture disease: 7-year experience of two-stage urethroplasty in a high volume UK centre : P105
Do replacement artificial urinary sphincters last as long as the first implanted? : P106
Does radiotherapy affect outcome following bulbar artificial urinary sphincter implantation for sphincter weakness incontinence resulting from prostate cancer treatment? : P107
Surgical repair of uro-rectal and perineal fistulae : P108
Can filling phase urodynamic parameters predict the success of artificial urinary sphincter in treating post-prostatectomy incontinence? : P109
Men with locally advanced prostate cancer excluded from the ProtecT Trial: early detection produces better outcomes : P110
Prostate biopsy: It's not NICE for UK urologists : P111
The use of dynamic micromechanical markers in the detection of prostate cancer: Results of an in-vivo and ex-vivo study : P112
Concordance of transperineal, transrectal and transperineal sector-based template approaches with 305 radical prostatectomies: A multicentre study : P113
Transperineal targeted prostate biopsy in the outpatients setting : P114
Prostate specific membrane antigen (PSMA) CT PET imaging in prostate cancer: A revolution in patient care : P115
MRI invisible prostate cancer – Can we discharge patients with Pi-RADS score 1 or 2 without a prostate biopsy? : P116
DCE-MRI then ultrasound fusion biopsy (UFB) protocols will fail to identify significant intermediate and some high-grade tumour when compared to transperineal saturation biopsy (TPSB) : P117
The diagnostic value of MRI-based PSA density to predict the outcome of primary transperineal sector-guided prostate biopsy : P118
MRI-US fusion targeted biopsy: Optimising the combination of biopsy cores : P119
Transperineal MRI-targeted biopsy versus transperineal template prostate mapping biopsy in the detection of localised radio-recurrent prostate cancer : P120
Accuracy of preoperative magnetic resonance imaging and D'Amico risk classification in detecting extracapsular extension of prostate cancer : P121
The safety and efficacy of performing day-case holmium laser enucleation of the prostate (HoLEP) : P122
Is power everything in HoLEP surgery? The first reported 50W HoLEP series : P123
Holmium laser enucleation versus transurethral resection of the prostate for urinary retention – Peri-operative and longterm outcomes from a single centre experience : P124
Routine post-operative blood tests following Holmium Laser Enucleation of the Prostate (HoLEP): Are they clinically useful? : P125
24-month functional results of a prospective randomized controlled study comparing GreenLight XPS to TURP for durability, efficacy and safety (GOLIATH) : P126
Prostate artery embolisation – Initial experience of treatment of benign prostatic enlargement for large volume prostates (mean volume 135cc) at a single institution : P127
Early clinical experience in Melbourne of a novel treatment for BPH: aquablation – Image guided robotic waterjet ablation of the prostate : P128
Predicting outcome from bladder outlet surgery using volume-corrected flow rate : P129
Community management of male patients with lower urinary tract symptoms (LUTS) in the UK : P130
Changing trends of minimally invasive benign prostate hyperplasia (BPH) intervention in England: Evidence from hospital episodes statistics (HES) database : P131
Altered expression of markers of epithelial-to-mesenchymal transition at the extraprostatic extension component of locally invasive prostate cancers : P132
Global metabolite profiling of the peripheral and transition zones of the prostate : P133
Defining the role of plexin-B1 in the progression of prostate cancer : P134
Patient-derived first generation xenografts of prostate cancers: promising tools for predicting drug responses for personalised chemotherapy : P135
CD8 T cells inhibit the IL-15 induced expansion of effector cells and the cytotoxic activity of NK cells toward tumour cells in the prostate cancer microenvironment : P136
Electrical stimulation of the spinal dorsal root inhibits reflex bladder contraction and external urethra sphincter activity: Is this how sacral neuromodulation works? : P137
Mechanical, histological and biochemical analysis of benign hyperplastic prostate tissue : P138
A study of the effects of hydrogen sulphide and cyclosporine in renal reperfusion injury : P139
The ‘be clear on bladder cancer campaign’ significant increase in referrals with no change in urological cancers diagnosed : P140
Reducing the economic burden and morbidity of low-grade TCC bladder; an outcomes analysis to inform future guidelines : P141
Out-patient transurethral laser ablation (TULA) of urothelial tumours using the 1470 nm diode laser : P142
Day case TURBT: the new UK gold standard? : P143
BCG efficacy differs according to the strain used – Implications in an era of BCG shortages : P144
Visceral adipose tissue on preoperative CT scan for urothelial bladder cancer and correlating outcomes after radical cystectomy : P145
The effects of centralization and surgical volume on radical cystectomy for high risk non-muscle-invasive bladder cancer in the UK: An analysis of trends over 10 years from the BAUS section of oncology radical cystectomy database : P146
Long-term oncological outcomes of patients undergoing neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer : P147
Introduction of robotic cystectomy confers additional reduction in length of stay (LOS) in an established enhanced recovery programme (ERP) : P148
Laparoscopic cystectomy outcomes for a single centre : P149